Speciality Medicines IPO Review & Recommendations

Bookbuilding IPO | ₹29 Cr | Listed at BSE SME | Fri, Mar 20, 2026 - Tue, Mar 24, 2026

IPO Recommendations (0 Reviews)

Review ByApplyMay ApplyNeutralAvoidNot Rated
Count00000
%00000

Peer Comparison

Speciality Medicines Ltd. peer comparison with similar listed entities. (As on March 31, 2025)

Company NameEPS (Basic)EPS (Diluted)NAV (₹ per share)P/E (x)RoNW (%)Financial statements
Speciality Medicines Ltd.14.1014.1047.2628.42
Remus Pharmaceuticals Ltd.65.2165.21434.2510.4115.02
Trident Lifeline Ltd.10.2210.2256.0527.0018.23
Mono Pharmacare Ltd.1.751.7517.667.499.90

Notes:

  • P/E ratio has been computed based on the closing market price of equity shares on the BSE-NSE website on Feb 24, 2026 divided by diluted EPS for the period ended March 31, 2025.
  • RoNW is computed as profit attributable to the owners of the company divided by the net worth.
  • NAV is computed as the closing net worth divided by the closing outstanding number of equity shares.

IPO Review by Members

Speciality Medicines IPO Reviews, analysis and views by popular members.

Post Manage

Review ByApplyMay ApplyNot RatedAvoid
Count0000
%0.000.000.000.00
MemberReview
No recommendation found. Be the first to post the recommendation.

  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.
Open an Instant Account with Zerodha